Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fineness of Cement01:15

Fineness of Cement

539
The fineness of cement directly influences the rate of hydration, as the hydration begins at the surface of the cement particles. In addition to hydration, the fineness of cement is vital for various properties of concrete including workability, gypsum requirement, and long-term behavior. The fineness of cement is represented in terms of the specific surface of cement which is typically measured in square meters per kilogram, with several methods available for this determination.
Direct...
539
Fineness Modulus01:19

Fineness Modulus

1.5K
The fineness modulus (FM) of aggregate is a numerical index that measures the coarseness or fineness of the particles. It is calculated by adding the cumulative percentages of aggregate retained on each of a specified series of sieves and dividing the sum by 100.
Consider performing sieve analysis on sand through a set of ASTM sieves. The weight of aggregate retained in each sieve and pan placed at the bottom is recorded, as given in Column B of Table 1.
To determine the fineness modulus of...
1.5K
Acids, Bases and Neutralization Reactions03:26

Acids, Bases and Neutralization Reactions

64.0K
An acid-base reaction is one in which a hydrogen ion, H+, is transferred from one chemical species to another. Such reactions are of central importance to numerous natural and technological processes, ranging from the chemical transformations within cells or lakes and oceans to the industrial-scale production of fertilizers, pharmaceuticals, and other substances essential to the society.
64.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TITE-safety: a robust time-to-event safety monitoring approach for clinical trials.

Biometrics·2026
Same author

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Blood advances·2026
Same author

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

bioRxiv : the preprint server for biology·2026
Same author

Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study.

Journal of human immunity·2026
Same author

Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation.

JCO oncology practice·2025
Same author

Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

7.7K

A group sequential test for treatment effect based on the Fine-Gray model.

Michael J Martens1, Brent R Logan2

  • 1The Emmes Corporation, Rockville, Maryland, U.S.A.

Biometrics
|March 14, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces a new group sequential test for clinical trials with competing risks endpoints, allowing for covariate adjustment. The method maintains statistical power and error rates, enhancing treatment effect analysis.

Keywords:
Competing risks analysisCovariate adjustmentFine-gray regression modelGraft versus host diseaseGroup sequential designHematopoietic cell transplantation

More Related Videos

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K

Related Experiment Videos

Last Updated: Feb 13, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
03:59

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy

Published on: January 10, 2019

7.7K
Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.5K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.3K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Survival Analysis

Background:

  • Competing risks endpoints are common in clinical trials, necessitating methods to analyze treatment effects on specific causes of failure.
  • Existing group sequential methods for competing risks do not allow for covariate adjustment, potentially limiting their power and applicability.
  • Covariate adjustment in regression models can improve the power to detect treatment differences by accounting for patient characteristics.

Purpose of the Study:

  • To propose a novel group sequential test for treatment effects in the presence of competing risks that allows for covariate adjustment.
  • To demonstrate the theoretical properties of the proposed test, including its asymptotic distribution and suitability for standard group sequential designs.
  • To evaluate the performance of the proposed method in a real-world clinical trial and through simulation studies.

Main Methods:

  • Development of a group sequential test based on the Fine-Gray model for competing risks data.
  • Derivation of the asymptotic distribution of the test statistics, showing an independent increments structure.
  • Application of standard group sequential design techniques (e.g., O'Brien-Fleming, error spending functions).
  • Reanalysis of the BMT CTN 0402 phase III clinical trial data.
  • Simulation study of randomized group sequential trials with influential covariates.

Main Results:

  • The proposed group sequential test, based on the Fine-Gray model, successfully adjusts for covariates.
  • The test statistics exhibit an asymptotic distribution with independent increments, enabling the use of established group sequential design methods.
  • Reanalysis of BMT CTN 0402 demonstrated the practical application of the method.
  • Simulation studies confirmed that the proposed method preserves type I error rate and power at nominal levels, even with influential covariates.

Conclusions:

  • The developed group sequential test provides a robust method for analyzing treatment effects in clinical trials with competing risks and covariates.
  • This approach enhances the ability to detect treatment differences by accounting for patient characteristics, improving trial efficiency.
  • The method is suitable for standard group sequential designs, offering flexibility and power in clinical trial analysis.